- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07617857
Whole-Body Cryotherapy and Isokinetic Performance After Exercise-Induced Fatigue (WBC-ISO)
Effect of Whole-Body Cryotherapy on Isokinetic Performance After Exercise-Induced Fatigue
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
This study was designed to investigate the effects of whole-body cryotherapy (WBC) on recovery and isokinetic muscle performance following exercise-induced fatigue in physically active healthy male university students. Exercise-induced fatigue is associated with reduced muscle force production, impaired performance, and increased injury risk. Various recovery strategies have been used to minimize these negative effects, and WBC has gained increasing attention in sports medicine because of its potential physiological and neuromuscular recovery benefits.
The study used a randomized within-subject crossover design in which participants completed two recovery conditions, WBC and passive rest, on separate days following a standardized treadmill-based fatigue protocol. During the WBC condition, participants were exposed to a two-stage cryogenic chamber consisting of an adaptation chamber at -30°C followed by a main chamber at -85°C. Passive rest sessions were performed under the same laboratory conditions without cryotherapy exposure.
Primary outcome measures included isokinetic knee extension and flexion performance assessed at angular velocities of 60°/s and 240°/s using an isokinetic dynamometer. Peak torque and body mass-normalized peak torque values were analyzed for both dominant and non-dominant lower extremities. Secondary outcome measures included systolic and diastolic blood pressure, heart rate, oxygen saturation, and perceived fatigue responses measured throughout the recovery period.
The aim of the study was to determine whether WBC provides superior recovery effects compared with passive rest following running-induced acute fatigue.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Istanbul
-
Istanbul, Istanbul, Turquia (Türkiye), 34000
- Istanbul University
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Healthy male participants aged 18-30 years with no exercise limitation
- No history of knee or lower-extremity injury requiring physiotherapy or surgical intervention
- No current lower-extremity pain
- No limitation in lower-extremity range of motion
- No chronic disease
- No mental or psychological disorder
Exclusion Criteria:
- Presence of cardiovascular disease
- Presence of respiratory disease
- History of cold allergy
- Presence of a tumor-related disease
- Presence of a viral or bacterial infection
- Diagnosis of Raynaud's disease
- Presence of claustrophobia
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Whole-Body Cryotherapy
Participants underwent whole-body cryotherapy following the running-induced fatigue protocol.
|
Participants underwent whole-body cryotherapy following a standardized running-induced fatigue protocol.
The intervention was performed in a two-stage cryogenic chamber consisting of a 30-second adaptation phase at -30°C followed by a 3-minute exposure at -85°C.
|
|
Sem intervenção: Passive Rest
Participants completed passive seated rest following the running-induced fatigue protocol.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Peak Torque During Knee Extension and Flexion
Prazo: Immediately after the 30-minute recovery period
|
Assessment of isokinetic knee extension and flexion peak torque at 60°/s and 240°/s following whole-body cryotherapy and passive rest recovery conditions.
|
Immediately after the 30-minute recovery period
|
|
Peak Torque Normalized to Body Mass
Prazo: Immediately after the 30-minute recovery period
|
Assessment of body mass-normalized peak torque values during isokinetic knee extension and flexion testing at 60°/s and 240°/s.
|
Immediately after the 30-minute recovery period
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Heart Rate
Prazo: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
Assessment of heart rate responses throughout the recovery period following exercise-induced fatigue.
|
Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
|
Blood Pressure
Prazo: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
Assessment of systolic and diastolic blood pressure responses throughout the recovery period.
|
Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
|
Oxygen Saturation
Prazo: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
Assessment of peripheral oxygen saturation during the recovery period.
|
Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
|
Perceived Fatigue
Prazo: Immediately after exercise, 5 minutes, and 10 minutes after exercise
|
Assessment of perceived fatigue using the Borg Rating of Perceived Exertion (RPE) Scale (6-20 points).
Scores range from 6 (no exertion) to 20 (maximal exertion), with higher scores indicating greater perceived fatigue and exertion.
|
Immediately after exercise, 5 minutes, and 10 minutes after exercise
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Publicações Gerais
- Krueger M, Costello JT, Achtzehn S, Dittmar KH, Mester J. Whole-body cryotherapy (-110 degrees C) following high-intensity intermittent exercise does not alter hormonal, inflammatory or muscle damage biomarkers in trained males. Cytokine. 2019 Jan;113:277-284. doi: 10.1016/j.cyto.2018.07.018. Epub 2018 Jul 19.
- Abaidia AE, Lamblin J, Delecroix B, Leduc C, McCall A, Nedelec M, Dawson B, Baquet G, Dupont G. Recovery From Exercise-Induced Muscle Damage: Cold-Water Immersion Versus Whole-Body Cryotherapy. Int J Sports Physiol Perform. 2017 Mar;12(3):402-409. doi: 10.1123/ijspp.2016-0186. Epub 2016 Aug 24.
- Wilson LJ, Cockburn E, Paice K, Sinclair S, Faki T, Hills FA, Gondek MB, Wood A, Dimitriou L. Recovery following a marathon: a comparison of cold water immersion, whole body cryotherapy and a placebo control. Eur J Appl Physiol. 2018 Jan;118(1):153-163. doi: 10.1007/s00421-017-3757-z. Epub 2017 Nov 10.
- Rose C, Edwards KM, Siegler J, Graham K, Caillaud C. Whole-body Cryotherapy as a Recovery Technique after Exercise: A Review of the Literature. Int J Sports Med. 2017 Dec;38(14):1049-1060. doi: 10.1055/s-0043-114861. Epub 2017 Nov 21.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- 2024/1567
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .